
    
      An open-label, randomized, multiple-dose, 2-sequence, 2-period, 2-treatment, crossover study

      Part1: Examining how D086 affects pharmacokinetics of CKD-330. Part2: Examining how CKD-330
      affects pharmacokinetics of D086.
    
  